Two unrelated boys with typical clinical and bioTerm large for gestational age neonates are at increased risk for hypoglycemia. It was postulated that identification of term features Of GSD Type I had increased
features Of GSD Type I had increased
LGA newborns by the Portland Intrauterine Growth Curve as opposed in liver but normal glucose-6-phosphatase activity (assayed after freezing). whereas only 7 of these 11 neonates were identified by the growth rates but had no effect on the neutropenia.
Portland Graph as LGA. We conclude that in our population the Bone is the major storehouse of the body burden of Pb in man. Nonetheless, the biological significance of bone Pb is largely unknown. Studies in bone organ culture have shown that one subcompartment of bone Pb is readily exchangeable and the source of Pb chelated by CaNa2EDTA. This subcompartment of bone Pb invitro is regulated by the same hormones and ions that normally control bone cell metabolism. To characterize this subcompartment at the cellular level, bone cell populations from mouse calvaria were enriched for osteoclasts (OC) and osteoblasts (OB) by collagenase digestion. Once cells grew to confluency, OC and OB cells were subcultured in multiwells to which fresh medium and 210~b were added. After cubation with 2 1 0~ for 48 H, labelled cells were chased with 2'$b-free medium. 218Pb uptake was present by 1 H; a plateau was reached by 10H: OC: 4.51 x lo3 cpm/mg cell protein; OB: 1.1 lo3 cpmlmg cell protein. Uptake increased linearly as medium "k'b was increased; b 48 H, OC accumulated 4-5 times more cpm compared to OB. In 210Pb-free medium, OC and OB cells released 29.2 f 1.1 and 5.6 + .9%, respectively, of preincorporated label by 10 H. Vigorous washing of ce with CaNa2EDTA, trypsin and TCA indicated that virtually all " ' P b incorporation was intracellular. These data suggest that: 1) OC and OB cells incorporate 210~b rapidly; a significant fraction of incorporated label is exchangeable; 2) In this system, OC appear to be the major cell type involved in the metabolism of Pb in bone. We have previously demonstrated that somatomedin (SM) can induce the loss of specific SM-C receptors on cultured IM-9 lymphocytes in a time-and concentration-dependent manner. To inveatigate the acute regulation of SM binding under in vivo conditions, we have evaluated SM receptors on circulating mononuclear cells obtained from 12 hypopituitary dwarfs prior to and after 4 days administration of hGH, 0.1 Ulkglday. Plasma SM levels, measured by radioreceptorassay, rose from 0.37 + 0.08 U/ml (mean + SEM) to 1.00 + 0.10 (p g.001). Concomitantly, specific binding of 125-I-SM-C to 50 x10 nononuclear cell.s/ml fell from 13.615 0.97% to 10.40 5 0.85% (p 0.02). Scatchard analysis demonstrated that the decrease in specific binding was predominantly secondary to a reduced number of SM-C receptor sites per cell, with no alteration in receptor affinity. Overall, a significant inverse correlation was observed between plasma SM levels and mononuclear cell binding of 125-I-SM-C (r=-0.62, p< 0.001).
MODULATION OF SOMATOMEDIN RECEPTOR SITES IN GROWTH
The data demonstrate that treatment of hypopituitarism with conventional therapeutic doses of hGH results in significant acute increases in plasma SM levels in the majority of subjects, with a reciprocal decline in the specific binding of 125-I-SM-C. We conclude that SM, like insulin, is capable of regulating homologous receptor concentrations under both in vitro and in vivo conditions. The variations in blood ketone bodies (BKB), blood glucose (BG) and insulin were studied in 19 normal and 14 hypoglycemic children aged 4 months to 13 years during a 24 hour fast. Except in 4 patients (2 with hyperinsulinism, 2 with defect in ketogenesis), a significant and parallel increase in BKB was observed in controls and patients from Oh to 20h (in mmol/l, meaW&D) 0.20M.16 at Oh, 1.54S.26 at 15h, 3.05h1.45 at 20h, 3.87f1.48 at 24h. A significant progressive decrease in glucose levels was observed from Oh to 20h but not from 20h on (in mg/dl) llM6.4 at Oh, 74,5A6 at 15h, 60f15.5 at 20h, 59.57d3 at 24h. A highly negative correlation between BKB and BG was found at each time of fasting (rlr0.54, p<,001 with a large dispersion of BKB especially for the ones corresponding to the BG between 45 and 65 mg/dl (SD=1.75mM). This dispersion was consistently reduced in a homogenous age group 4-6 years presenting with similar glucose levels (S~=0.92mM). There was a positive correlation between age and BG from 21h on (r20.61, p10,01), and an inverse relationship between age and BKB from 15h on (r>-0.43, p<0.001).
PLASMA KETONE BODIES DURING
The same high inverse relationship between age and BKB was again observed when the variable of glucose level was factored out (r=-0.73, p<0.001) demonstrating that the variation in BKB is indeed related to age. These findings desem attention for the interpretation of fasting BKB especially when used as an aid in the diagnosis of the various formsofchildhood hypoglycemia, and hypoketotic states. An association of microvesicular hepatic fatty change with hyperammonemia and orotic aciduria (OAuria) has been noted in several pediatric conditions, including Reye's syndrome. Experimental OA supplementation produces fatty changes in rat liver. In the present study severe hyperammonemia (2-3 mg%) , without OAuria was produced by repeated administration of urease (25 ~Ikg) for periods up to 24 hrs. The hyperamonemic rats were found to have hyperglycemia (374221 mg%: controls: 17226 mg%) , elevated plasma FFA (815262 pEq/l: controls 491525 )~~q/l) and hepatic triglycerides (15.621.4 mglgm: controls: 2.720.2 rnglgm) (SEM) . Liver sections stained with oil red 0 showed microvesicular fatty changes. To evaluate the role of OA in the development of fatty changes, conversion of OA to uridine monophosphate (UMP) was blocked with azauridine. Under these conditions fatty changes resulting from urease-induced hyperammonemia were markedly less than those observed without azauridine. It is concluded that increased availability of carbamyl phosphate in hyperammonemia leads to overproduction of OA and that the conversion of increased amounts of OA to UMP rather than OA elevation was an essential prerequisite to the induction of hepatic microvesicular fatty changes.
